99 related articles for article (PubMed ID: 17172423)
1. Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis.
Park C; Lee I; Kang WK
Mol Cancer Ther; 2006 Dec; 5(12):3191-6. PubMed ID: 17172423
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of inwardly rectifying potassium channel Kir2.2 suppresses tumorigenesis by inducing reactive oxygen species-mediated cellular senescence.
Lee I; Park C; Kang WK
Mol Cancer Ther; 2010 Nov; 9(11):2951-9. PubMed ID: 20841375
[TBL] [Abstract][Full Text] [Related]
3. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.
Albino D; Civenni G; Rossi S; Mitra A; Catapano CV; Carbone GM
Oncotarget; 2016 Nov; 7(47):76756-76768. PubMed ID: 27732936
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid induces cellular senescence via upregulation of p16, p21, and p27.
Park SH; Lim JS; Jang KL
Cancer Lett; 2011 Nov; 310(2):232-9. PubMed ID: 21803488
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
[TBL] [Abstract][Full Text] [Related]
6. Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo.
Hu Z; Zhang D; Hao J; Tian K; Wang W; Lou H; Yuan H
Cancer Chemother Pharmacol; 2014 Feb; 73(2):397-407. PubMed ID: 24322375
[TBL] [Abstract][Full Text] [Related]
7. A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment.
Lee I; Yeom SY; Lee SJ; Kang WK; Park C
Cancer Res; 2010 Jun; 70(11):4357-65. PubMed ID: 20460530
[TBL] [Abstract][Full Text] [Related]
8. Rb and E2F-1 regulate telomerase activity in human cancer cells.
Crowe DL; Nguyen DC
Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
Mol Carcinog; 2016 Jun; 55(6):1048-59. PubMed ID: 26258986
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3β Depletion Drives a Senescence Program in Glioblastoma Cells Through the ERK/SKP2/p27 Pathway.
Seo SB; Lee JJ; Yun HH; Im CN; Kim YS; Ko JH; Lee JH
Mol Neurobiol; 2018 Feb; 55(2):1259-1270. PubMed ID: 28116547
[TBL] [Abstract][Full Text] [Related]
12. BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.
Lee JJ; Lee JS; Cui MN; Yun HH; Kim HY; Lee SH; Lee JH
Cell Death Dis; 2014 Nov; 5(11):e1537. PubMed ID: 25412315
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescence.
Falcone G; Mazzola A; Michelini F; Bossi G; Censi F; Biferi MG; Minghetti L; Floridia G; Federico M; Musio A; Crescenzi M
Aging Cell; 2013 Apr; 12(2):312-5. PubMed ID: 23167636
[TBL] [Abstract][Full Text] [Related]
15. Low p16
Graham MK; Principessa L; Antony L; Meeker AK; Isaacs JT
Prostate; 2017 Mar; 77(4):374-384. PubMed ID: 27859428
[TBL] [Abstract][Full Text] [Related]
16. Function of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi N; Shimada K; Nakamura M; Ishida E; Ota I; Tanaka N; Fujimoto K
Clin Cancer Res; 2008 Jul; 14(14):4408-16. PubMed ID: 18628455
[TBL] [Abstract][Full Text] [Related]
17. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
18. Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin.
Zhang Y; Dong Y; Melkus MW; Yin S; Tang SN; Jiang P; Pramanik K; Wu W; Kim S; Ye M; Hu H; Lu J; Jiang C
Mol Cancer Ther; 2018 Nov; 17(11):2341-2352. PubMed ID: 30166403
[TBL] [Abstract][Full Text] [Related]
19. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
[TBL] [Abstract][Full Text] [Related]
20. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27
Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G
Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
